Tegoprazan and its Impurities
Tegoprazan is a novel P-CAB that may provide a new option for therapy in gastric acid-related diseases as well as in gastrointestinal motility-impaired diseases in clinical Reference standards of Tegoprazan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


(S)-4-((5,7-Difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide
(S)-4-((5,7-Difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide
Catalogue No.:PA 73 0041008
CAS :
942485-42-9
Molecular Formula : C27H25F2N3O5S
Molecular Weight : 541.57


7-(((S)-7-(((S)-5,7-Difluorochroman-4-yl)oxy)-5-fluorochroman-4-yl)oxy)-N,N,2-trimethyl-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamide
7-(((S)-7-(((S)-5,7-Difluorochroman-4-yl)oxy)-5-fluorochroman-4-yl)oxy)-N,N,2-trimethyl-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamide
Catalogue No.:PA 73 0041009
CAS :
NA
Molecular Formula : C29H28F3N3O5
Molecular Weight : 555.55


(-)-7-[(5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-yl)oxy]-2-methyl-1H-benzimidazole-5-carboxylic Acid
(-)-7-[(5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-yl)oxy]-2-methyl-1H-benzimidazole-5-carboxylic Acid
Catalogue No.:PA 73 0041015
CAS :
942196-03-4
Molecular Formula : C18H14F2N2O4
Molecular Weight : 360.32


(S)-1-Benzyl-4-((5,7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide
(S)-1-Benzyl-4-((5,7-difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide
Catalogue No.:PA 73 0041017
CAS :
2975125-72-3
Molecular Formula : C27H25F2N3O3
Molecular Weight : 477.51


(S)-7-((5,7-Difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1-nitroso-1H-benzo[d]imidazole-5-carboxamide
(S)-7-((5,7-Difluorochroman-4-yl)oxy)-N,N,2-trimethyl-1-nitroso-1H-benzo[d]imidazole-5-carboxamide
Catalogue No.:PA 73 0041018
CAS :
NA
Molecular Formula : C20H18F2N4O4
Molecular Weight : 416.38